As an oncogenic protein, NSD2 is overexpressed in a variety of cancer cells (Vougiouklakis, Hamamoto, Nakamura, & Saloura, 2015), and knockdown of NSD2 decreases proliferation in cancer cells at least in part by loss of H3K36me2 levels (García‐Carpizo et al., 2016; Kuo et al., 2011). The gene discussed is NSD2; the disease is cancer.